Methods for treating inflammation-mediated conditions of the eye II

Details for Australian Patent Application No. 2007200122 (hide)

Owner Allergan, Inc.

Inventors Wong, Vernon G.; Hu, Mae W.L.

Agent FB Rice

Pub. Number AU-B-2007200122

Parent 2005246995

Filing date 11 January 2007

Wipo publication date 1 February 2007

Acceptance publication date 15 May 2008

International Classifications

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

A61K 47/34 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds

Event Publications

25 January 2007 Complete Application Filed

1 February 2007 Application Open to Public Inspection

  Published as AU-B-2007200122

15 May 2008 Application Accepted

  Published as AU-B-2007200122

11 September 2008 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007200123-Nerve proximity and status detection system and method

2007200121-Injection port